Chemical Compound

Dinoprostone; (Z)-7-[(1R,2R,3R)-3-hydroxy-2-[(E)-(3S)-3-hydroxyoct-1-enyl]-5-oxocyclopentyl]hept-5-enoic acid; PGE2

CAS Registry Number 363-24-6
返回搜索 申请报价
Dinoprostone; (Z)-7-[(1R,2R,3R)-3-hydroxy-2-[(E)-(3S)-3-hydroxyoct-1-enyl]-5-oxocyclopentyl]hept-5-enoic acid; PGE2 结构式
Primary record

Dinoprostone; (Z)-7-[(1R,2R,3R)-3-hydroxy-2-[(E)-(3S)-3-hydroxyoct-1-enyl]-5-oxocyclopentyl]hept-5-enoic acid; PGE2

库存
3,419 克
纯度
98.8 %
CAS
363-24-6

化合物标识与属性

CAS
363-24-6
PubChem CID
5280360
SMILES
CCCCC[C@@H](/C=C/[C@H]1[C@@H](CC(=O)[C@@H]1C/C=C\CCCC(=O)O)O)O
Canonical SMILES
CCCCC[C@H](O)/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1C/C=C\CCCC(=O)O

名称与同义词

  • Prostaglandin E2
  • Dinoprostone
  • PGE2
  • Prepidil
  • Prostin E2
  • Cervidil
  • Propess
  • Minprostin E2
  • Dinoproston
  • Minprositin E2
  • Prostin
  • Prostarmon E
  • Dinoprostonum
  • Dinoprostona
  • Cerviprost
  • Glandin
  • 363-24-6
  • Cerviprime
  • Prostenone
  • Enzaprost E
  • l-Prostaglandin E2
  • PGE2alpha
  • primiprost
  • (15S)-Prostaglandin E2
  • Prostenon
  • l-PGE2
  • Prostaglandin E
  • Prepidil Gel
  • Prostin E
  • PGE2 alpha
  • Gel, Prepidil
  • Prostarmon E2
  • Prostaglandin E2alpha
  • E2, Prostaglandin
  • Cervidil (TN)
  • Prepidil (TN)
  • Dinoprostone CRS
  • Prostaglandin,PGE2
  • (-)-Prostaglandin E2
  • l-ProstagladinE2
  • [3H]dinoprostone
  • alpha, PGE2
  • Prostaglandin E2 alpha
  • prosta-glandin e2
  • Prostaglandin E(2)
  • Prostin E2 (TN)
  • Dinoprostone betadex
  • Prestwick_793
  • Propess (TN)
  • Dinoprostonum [INN-Latin]
  • E2alpha, Prostaglandin
  • [3H]prostaglandin E2
  • Dinoprostona [INN-Spanish]
  • [3H]prostin E2
  • 5-trans-PGE2
  • alpha, Prostaglandin E2
  • E2 alpha, Prostaglandin
  • VIVELLE-DOT
  • 8-isoprostaglandin E2
  • AC1NQWXW
  • K7Q1JQR04M
  • Prostaglandin E2 (GMP)
  • Prostin (prostaglandin)
  • CHEMBL548
  • Dinoprostone Prostaglandin E2
  • RefChem:56458
  • UNII-K7Q1JQR04M
  • Prostaglandin E2.alpha.
  • [3H]PGE2
  • Alprostadil EP Impurity G
  • DINOPROSTONE [INN]
  • DINOPROSTONE [JAN]
  • DTXSID4022947
  • MFCD00077861
  • D06FEA
  • C20H32O5
  • Dinoprostone (JAN/USP/INN)
  • DINOPROSTONE [USAN]
  • (+/-)-Prostaglandin E2
  • U-12062
  • 5,6-cis-Prostaglandin E2
  • BML1-F07
  • DTXCID002947
  • NSC 165560
  • XEYBRNLFEZDVAW-ARSRFYASSA-N
  • DINOPROSTONE [VANDF]
  • PGE-2
  • SCHEMBL25533
  • BSPBio_001490
  • DINOPROSTONE [MART.]
  • Prostaglandin E2 (Standard)
  • CHEBI:15551
  • Dinoprostone [USAN:INN:BAN:JAN]
  • DINOPROSTONE [USP-RS]
  • DINOPROSTONE [WHO-DD]
  • NSC 196514
  • EINECS 206-656-6
  • Prostaglandin E2 (Cervidil)?
  • PROSTAGLANDIN E2 [MI]
  • GTPL1883
  • GTPL1916
  • orb1302168
  • PGE(2)
  • (5Z,11alpha,13E,15S)-11,15-dihydroxy-9-oxoprosta-5,13-dien-1-oic acid
  • Dinoprostone (Prostaglandin E2)
  • NSC-165560
  • NSC-196514
  • [3H]-PGE2
  • BDBM35847
  • Dinoprostone beta-Cyclodextrin Clathrate
  • DTXSID00859353
  • G02AD02
  • U 12062
  • DINOPROSTONE [ORANGE BOOK]
  • HMS1361K12
  • HMS1791K12
  • HMS1989K12
  • HMS2089D17
  • HMS3268J12
  • HMS3402K12
  • HMS3413C20
  • HMS3648F07
  • HMS3677C20
  • BMS-279654 & PGE2
  • DINOPROSTONE [EP MONOGRAPH]
  • DINOPROSTONE [USP IMPURITY]
  • (-)-PGE2
  • AMY30102
  • EX-A1773
  • MSK15026
  • ZINC3830713
  • Dinoprostone [USAN:BAN:INN:JAN]
  • DINOPROSTONE [USP MONOGRAPH]
  • Tox21_111196
  • Dinoprostone [USAN:USP:INN:BAN:JAN]
  • EBC-26697
  • HB3460
  • LMFA03010003
  • NCGC00092361-05
  • NSC165560
  • NSC196514
  • ONO-01676
  • s3003
  • AKOS015920228
  • Tox21_111196_1
  • AC-6098
  • C20-H32-O5
  • CCG-208092
  • CCG-208256
  • CID5280360
  • CS-6932
  • DB00917
  • FD31827
  • HY-101952G
  • HY-101952R
  • J9.243F
  • RP17686
  • Alprostadil EP Impurity G; Dinoprostone
  • IDI1_033960
  • SMP2_000056
  • (E,Z)-(1R,2R,3R)-7-(3-Hydroxy-2-((3S)-(3-hydroxy-1-octenyl))-5-oxocyclopentyl)-5-heptenoic acid
  • NCGC00092361-01
  • NCGC00092361-02
  • NCGC00092361-03
  • NCGC00092361-04
  • NCGC00092361-06
  • AJ-45765
  • AN-10387
  • AS-71847
  • BC219642
  • BR-72815
  • CAS-363-24-6
  • PGE2-[3,3,4,4-d4]
  • Prostaglandin E2, 98% - 10MG 10mg
  • SY057971
  • U-12,062
  • (5Z,13E,15S)-11alpha,15-dihydroxy-9-oxoprosta-5,13-dien-1-oic acid
  • Dinoprostone 100 microg/mL in Acetonitrile
  • HY-101952
  • LS-125823
  • (5Z,13E)-(15S)-11alpha,15-dihydroxy-9-oxoprosta-5,13-dienoate
  • (Z)-7-((1R,2R,3R)-3-Hydroxy-2-((S,E)-3-hydroxyoct-1-en-1-yl)-5-oxocyclopentyl)hept-5-enoic acid
  • ALPROSTADIL IMPURITY G [EP IMPURITY]
  • B7005
  • CS-0626105
  • NS00009026
  • P1884
  • U,062
  • (5Z,13E)-(15S)-11alpha,15-Dihydroxy-9-oxoprost-13-enoate
  • (Z)-7-[(1R,2R,3R)-3-Hydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]-5-oxocyclopentyl]hept-5-enoic acid
  • 1798-EP2272832A1
  • 1798-EP2277848A1
  • 1798-EP2277858A1
  • 1798-EP2295055A2
  • 1798-EP2298767A1
  • 1798-EP2301922A1
  • 1798-EP2305641A1
  • 1798-EP2305653A1
  • 1798-EP2308510A1
  • 1798-EP2308872A1
  • 1798-EP2311453A1
  • 1798-EP2311808A1
  • 1798-EP2311829A1
  • 1798-EP2314574A1
  • 1798-EP2314587A1
  • 1798-EP2316829A1
  • 7-(3-Hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentyl)-5-heptenoic acid
  • C00584
  • D00079
  • l-7-(3-Hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentyl)-5-heptenoic acid
  • Prostaglandin E2, >=93% (HPLC), synthetic
  • 5-Heptenoic acid, 7-(3-hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentyl)-
  • 9-oxo-11R,15S-dihydroxy-5Z,13E-prostadienoic acid
  • Prosta-5,13-dien-1-oic acid, 11,15-dihydroxy-9-oxo-, (5Z,11alpha,13E,15S)-
  • 363P246
  • A823207
  • EN300-22411484
  • Q416554
  • SR-01000946417
  • SR-05000001459
  • (5Z,11-alpha,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic acid
  • (Z)-7-[(1r,2r,3r)-3-Hydroxy-2-[(E,3s)-3-Hydroxyoct-1-Enyl]-5-Oxo-Cyclopentyl]hept-5-Enoic Acid
  • 5-Heptenoic acid, 7-(3-hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentyl)-, l-
  • SR-01000946417-1
  • SR-05000001459-1
  • SR-05000001459-3
  • SR-05000001459-4
  • (5Z,11alpha,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic
  • BRD-K26521938-001-04-9
  • BRD-K26521938-001-07-2
  • BRD-K26521938-001-09-8
  • (5Z)-7-[(1R,2R,3R)-3-hydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-5-oxocyclopentyl]hept-5-enoic acid
  • 05D31BD5-818B-4A92-8CFC-BEC19926A5B3
  • 11alpha,15alpha-Dihydroxy-9-ketoprosta-5,13-dienoic acid
  • B1370-286161
  • Prosta-5,13-dien-1-oic acid, (5Z,11-alpha,13E,15S)-11,15-dihydroxy-9-oxo-
  • (5Z,11.alpha.,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic acid
  • 2-AMINO-1-BENZO[1,3]DIOXOL-5-YL-ETHANONEHYDROCHLORIDE
  • 5-Heptenoic acid, 7-[3-hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentyl]-
  • 7-[3-Hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentyl]-5-heptenoic acid
  • Dinoprostone, European Pharmacopoeia (EP) Reference Standard
  • (5Z,13E)-(15S)-11alpha,15-Dihydroxy-9-oxoprost-13-enoic acid
  • (5Z,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic acid
  • (5Z,13E,15S)-11-alpha,15-dihydroxy-9-oxoprost-5,13-dienoate
  • 11alpha,15alpha-Dihydroxy-9-oxo-5-cis,13-trans-prostadienoic acid
  • 9-oxo-11R,15S-dihydroxy-5Z,13E-prostadienoic acid; Prostin E2
  • Dinoprostone, United States Pharmacopeia (USP) Reference Standard
  • Prosta-5, (5Z,11.alpha.,13E,15S)-11,15-dihydroxy-9-oxo-
  • Prosta-5, 11,15-dihydroxy-9-oxo-, (5Z,11.alpha.,13E,15S)-
  • Prosta-5, 11,5-dihydroxy-9-oxo-, (5Z,11.alpha.,13E,15S)-
  • (5Z,11?,13E,15S)-11,15-Dihydroxy-9-oxo-prosta-5,13-dien-1oic acid
  • (5Z,11|A,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dienoic acid
  • (5Z,11a,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic acid
  • (5Z,11alpha,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dienoic acid
  • (5Z,11I+/-,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dienoic acid
  • (5Z,11R,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-diene-1-oic acid
  • (5Z,13E)-(15S)-11alpha,15-Dihydroxy-9-oxoprosta-5,13-dienoic acid
  • (5Z,13E,15S)-11-alpha,15-dihydroxy-9-oxoprost-5,13-dienoic acid
  • (5Z,13E,15S)-11alpha,15-Dihydroxy-9-oxo-5,13-prostadien-1-oic acid
  • (5Z,13E,15S)-11alpha,15-Dihydroxy-9-oxo-5,13-prostadiene-1-oic acid
  • (5Z,13E,15S)-11alpha,15-Dihydroxy-9-oxoprosta-5,13-diene-1-oic acid
  • (5Z,13E,15S)-9-Oxo-11alpha,15-dihydroxyprosta-5,13-diene-1-oic acid
  • (Z)-7-((1R,2R,3R)-3-hydroxy-2-((S,E)-3-hydroxyoct-1-enyl)-5-oxocyclopentyl)hept-5-enoic acid
  • 11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic acid (5Z,11alpha,13E,15S)
  • 5Z,11alpha,13E,15S)-11,15-Dihydroxy-9-oxo-rosta-5,13-dien-1-oic acid
  • 7-[3-hydroxy-2-(3-hydroxy-1-octenyl)-5-oxo-cyclopentyl]-5-heptenoic acid
  • Prostaglandin E2, synthetic, powder, BioReagent, suitable for cell culture
  • (5Z,11alpha,12alpha,13E,15S)-11,15-dihydroxy-9-oxoprosta-5,13-dien-1-oic acid
  • (5Z,11alpha,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-diene-1-oic acid
  • (5Z,8R,13E,15S)-11alpha,15-Dihydroxy-9-oxoprosta-5,13-diene-1-oic acid
  • [5Z,11alpha,13E,15S,(-)]-11,15-Dihydroxy-9-oxoprosta-5,13-diene-1-oic acid
  • [5Z,11R,13E,15S,(-)]-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic acid
  • [5Z,11R,13E,15S,(-)]-11,15-Dihydroxy-9-oxoprosta-5,13-diene-1-oic acid
  • 5-Heptenoic acid, 7-(3-hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentyl)-(8CI)
  • 5-Heptenoic acid, 7-[3alpha-hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentyl]-
  • Prosta-5,13-dien-1-oic acid, 11,15-dihydroxy-9-oxo-, (5Z,11.alpha.,13E,15S)-
  • Prosta-5,13-dien-1-oic acid, 11,15-dihydroxy-9-oxo-, (5Z,11?,13E,15S)-
  • Prostaglandin E2, gamma-irradiated, powder, BioXtra, suitable for cell culture
  • (E,2R,3R)-7-[3-hydroxy-2-[(3S)-(3-hydroxy-1-octenyl)]-5-oxocyclopentyl]-5-heptenoic acid
  • (E,Z)-(1R,2R,3R)-7-[3-hydroxy-2-[(3S)-(3-hydroxy-1-octenyl)]-5-oxocyclopentyl]-5-heptenoic acid
  • (Z)-7-((1R,2R,3R)-3-hydroxy-2-((E,3S)-3-hydroxyoct-1-enyl)-5-oxocyclopentyl)hept-5-enoic acid
  • (Z)-7-((1R,3R)-3-hydroxy-2-((E,3S)-3-hydroxyoct-1-enyl)-5-oxocyclopentyl)hept-5-enoic acid
  • 206-656-6
  • 22230-04-2
  • Dinoprostone; (Z)-7-[(1R,2R,3R)-3-hydroxy-2-[(E)-(3S)-3-hydroxyoct-1-enyl]-5-oxocyclopentyl]hept-5-enoic acid; PGE2
  • P2E